FDA OKs 1st oral drug for anaemia in adults with thalassemia | India News
NEW DELHI: In a landmark advance for thalassemia care, US FDA has approved Mitapivat, the first oral treatment for anaemia in adults with thalassemia, covering both transfusion-dependent and non-transfusion-dependent alpha and beta disease. Clinicians and patient groups in India have welcomed the decision as a potential game changer for a lifelong genetic blood disorder that…